Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John DiGiovanni

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
Cancers|December 16, 2020
Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput ScreeningG Lavender Hackman, Meghan Collins, Xiyuan Lu, et al.
Cancer Biology & Therapy|July 13, 2012
Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cellsPiyanuch Wonganan, Woon-Gye Chung, Saijie Zhu, et al.
Carcinogenesis|October 12, 2002
Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR miceHeather E Kleiner, Suryanarayana V Vulimiri, Matthew F Starost, et al.
NPJ Precision Oncology|June 25, 2019
Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growthSabin Kshattry, Achinto Saha, Paul Gries, et al.
Pharmacogenetics and Genomics|April 30, 2005
Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variantsJennifer S Mammen, Heather E Kleiner, John DiGiovanni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2020
Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic CancerAchinto Saha, Shengyuan Zhao, Zhao Chen, et al.
Journal of Hepatology|February 14, 2012
The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 miceTakuya Kitamura, Kevin Connolly, Lynnsie Ruffino, et al.
G3 (Bethesda, Md.)|April 5, 2014
Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor developmentJoe M Angel, Erika L Abel, Penny K Riggs, et al.
The Journal of Investigative Dermatology|April 3, 2025
Current Efficacy and Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisSrivatsa Surya Vasudevan, Tanisha Patel, John DiGiovanni, et al.
Nanomedicine (London, England)|February 3, 2012
Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNAB Leticia Rodriguez, Xinran Li, Kaoru Kiguchi, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Cancers|December 16, 2020
Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput ScreeningG Lavender Hackman, Meghan Collins, Xiyuan Lu, et al.
Cancer Biology & Therapy|July 13, 2012
Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cellsPiyanuch Wonganan, Woon-Gye Chung, Saijie Zhu, et al.
Carcinogenesis|October 12, 2002
Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR miceHeather E Kleiner, Suryanarayana V Vulimiri, Matthew F Starost, et al.
NPJ Precision Oncology|June 25, 2019
Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growthSabin Kshattry, Achinto Saha, Paul Gries, et al.
Pharmacogenetics and Genomics|April 30, 2005
Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variantsJennifer S Mammen, Heather E Kleiner, John DiGiovanni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2020
Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic CancerAchinto Saha, Shengyuan Zhao, Zhao Chen, et al.
Journal of Hepatology|February 14, 2012
The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 miceTakuya Kitamura, Kevin Connolly, Lynnsie Ruffino, et al.
G3 (Bethesda, Md.)|April 5, 2014
Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor developmentJoe M Angel, Erika L Abel, Penny K Riggs, et al.
The Journal of Investigative Dermatology|April 3, 2025
Current Efficacy and Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisSrivatsa Surya Vasudevan, Tanisha Patel, John DiGiovanni, et al.
Nanomedicine (London, England)|February 3, 2012
Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNAB Leticia Rodriguez, Xinran Li, Kaoru Kiguchi, et al.
Pageof 18